Collectively, our findings provided preliminary evidence for the mechanism underlying BC progression, whereby decreased METTL1 disrupts m7G-methylation mediated translational control of GADD45A and RB1, ultimately leading to BC progression. Here, METTL1 is linked to breast cancer.